MDxHealth (MDXH) Revenue (2022 - 2026)

MDxHealth has reported Revenue for 5 years, with the latest figure at $27.4 million in Q1 2026.

• Quarterly Revenue rose 12.74% year-over-year to $27.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186.2 million (up 96.98% YoY) and the FY2025 annual result came in at $107.9 million, up 19.8% from the prior year.
• Revenue retreated to $27.4 million in Q1 2026 per MDXH's latest filing, from $29.5 million in the prior quarter.
• Over five years, Revenue peaked at $78.3 million in Q3 2025 and troughed at $11.2 million in Q3 2022.
• A 5-year average of $26.3 million and a median of $22.2 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2025 and 2026: Revenue jumped 235.94% in 2025, then increased 12.74% in 2026.
• Over 5 years, Revenue stood at $12.9 million in 2022, then surged by 50.48% to $19.4 million in 2023, then climbed by 27.53% to $24.7 million in 2024, then gained by 19.43% to $29.5 million in 2025, then retreated by 7.31% to $27.4 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $27.4 million, $29.5 million, and $78.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.